Cancer treatments often involve potent drugs that can lead to significant toxicity. By using prodrugs, researchers aim to enhance the targeting of chemotherapeutic agents specifically to cancer cells. This selective activation helps in lowering systemic exposure to the active drug, thus reducing the risk of adverse effects. Additionally, prodrugs can help in overcoming challenges such as poor drug absorption, rapid metabolism, or short half-life of active compounds.
